• Mathur, S., Okal, J., Musheke, M., Pilgrim, N., Patel, S.K., Bhattacharya, R. et al. (2018). High rates of sexual violence by both intimate and non-intimate partners experienced by adolescent girls and young women in Kenya and Zambia: Findings around violence and other negative health outcomes. PLoS ONE 13(9): e0203929.
• Pilgrim, N., Musheke, M., Fisher, R. H., Keating K., Mwale, J., Banda, L., Mulenga, D., Phiri, L., Geibel, S. & Tun, W. (2018). Quality of care and HIV service utilization among key populations in Zambia: a qualitative comparative analysis among female sex workers, men who have sex with men and people who use drugs. AIDS Care, DOI: 10.1080/09540121.2018.1524119.
• Merten, S., Ntalasha, H., & Musheke, M. (2016). Non-uptake of HIV testing in children at risk in two urban and rural settings in Zambia: a mixed-method study. PLoS ONE, 11(6): e0155510.
• Musheke, M., Ntalasha, H., Gari, S., Mckenzie, O., Bond, V., Martin-Hilber, A. & Merten, S. (2013). A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health, 13:220.
• Musheke, M., Bond, V. & Merten, S. (2013). Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: A qualitative study. AIDS Patient Care & STDs, 27(4):231-241.
• Musheke, M., Bond, V. & Merten, S. (2012). Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka Zambia. Journal of the International AIDS Society, 15(Suppl 1):17366.
• Merten, S., Kenter, E., McKenzie, O., Musheke, M., Ntalasha, H. & Martin-Hilber, A. (2010). Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Tropical Medicine and International Health, 15 (Suppl. 1): 1-18.

Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.

• Herce ME, Hoffmann CJ, Fielding K, Topp SM, Hausler H, Chimoyi L, Smith HJ, Chetty-Makkan CM, Mukora R, Tlali M, Olivier AJ, Muyoyeta M, Reid SE, Charalambous S. The Lancet HIV. 2020 [in press].

Gone But Not Lost: Implications for Estimating HIV Care Outcomes When Loss to Clinic Is Not Loss to Care.

• Edwards JK, Lesko CR, Herce ME, Murenzi G, Twizere C, Lelo P, Anastos K, Tymejczyk O, Yotebieng M, Nash D, Adedimeji A, Edmonds A. Epidemiology. 2020 Jul;31(4):570-577. doi: 10.1097/EDE.0000000000001201. PMID: 32483067

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

• Moodie Z, Walsh SR, Laher F, Maganga L, Herce ME, Naidoo S, Hosseinipour MC, Innes C, Bekker LG, Grunenberg N, Mann P, Yu C, deCamp AC, Miner MD, Yates NL, Heptinstall J, Mkhize NN, Dintwe O, Frahm N, Cohen KW, Allen M, Hutter J, Wagner R, Pantaleo G, McElrath MJ, Tomaras GD, Morris L, Montefiori DC, Andersen-Nissen E, Gray GE, Gilbert PB, Kublin JG; NIAID HVTN 100 and HVTN 111 trial teams. PLoS Med. 2020 May 22;17(5):e1003117. doi: 10.1371/journal.pmed.1003117. eCollection 2020 May. PMID: 32442195

Phase 1 HIV vaccine trial to evaluate the safety and immunogenicity of HIV subtype C DNA and MF59-adjuvanted subtype C Env protein.

• Phase 1 HIV vaccine trial to evaluate the safety and immunogenicity of HIV subtype C DNA and MF59-adjuvanted subtype C Env protein. Hosseinipour MC, Innes C, Naidoo S, Mann P, Hutter J, Ramjee G, Sebe M, Maganga L, Herce ME, deCamp AC, Marshall K, Dintwe O, Andersen-Nissen E, Tomaras GD, Mkhize N, Morris L, Jensen R, Miner MD, Pantaleo G, Ding S, Van Der Meeren O, Barnett SW, McElrath MJ, Corey L, Kublin JG. Clin Infect Dis. 2020 Jan 4:ciz1239. doi: 10.1093/cid/ciz1239. Online ahead of print. PMID: 31900486

Effects of real-time electronic data entry on HIV programme data quality in Lusaka, Zambia.

• Moomba K, Williams A, Savory T, Lumpa M, Chilembo P, Tweya H, Harries AD, Herce M. Public Health Action. 2020 Mar 21;10(1):47-52. doi: 10.5588/pha.19.0068. PMID: 32368524Free PMC article.

"It's Not Like Taking Chocolates": Factors Influencing the Feasibility and Sustainability of Universal Test and Treat in Correctional Health Systems in Zambia and South Africa.

• Topp SM, Chetty-Makkan CM, Smith HJ, Chimoyi L, Hoffmann CJ, Fielding K, Reid SE, Olivier AJ, Hausler H, Herce ME, Charalambous S. Glob Health Sci Pract. 2019 Jun 27;7(2):189-202. doi: 10.9745/GHSP-D-19-00051. Print 2019 Jun. PMID: 31249019

Re-thinking Linkage to Care in the Era of Universal Test and Treat: Insights from Implementation and Behavioral Science for Achieving the Second 90.

• Herce ME, Chi BH, Liao RC, Hoffmann CJ. AIDS Behav. 2019 Sep;23(Suppl 2):120-128. doi: 10.1007/s10461-019-02541-5. PMID: 31161462

Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.

• Herce ME, Morse J, Luhanga D, Harris J, Smith HJ, Besa S, Samungole G, Kancheya N, Muyoyeta M, Reid SE. BMC Infect Dis. 2018 Oct 26;18(1):536. doi: 10.1186/s12879-018-3392-2. PMID: 30367622

Coordinating the prevention, treatment, and care continuum for HIV-associated tuberculosis in prisons: a health systems strengthening approach.

• Herce ME, Muyoyeta M, Topp SM, Henostroza G, Reid SE. Curr Opin HIV AIDS. 2018 Nov;13(6):492-500. doi: 10.1097/COH.0000000000000505. PMID: 30222608Review.